Purdue Pharma Signs 159,000-SF Lease in Stamford

The company's headquarters will remain at 201 Tresser Blvd., a more than 500,000-sf building the private pharmaceutical firm owns. Approximately 400 employees will be housed at the new office GlobeSt.com has learned. CBRE would not disclose how much space Purdue Pharma occupied at the 201 Tresser Blvd. location. The deal was announced by New York City-based Benenson Capital Partners LLC, the owner of the 260,000-sf six-story 1600 Summer St. property. Richard A. Kessler, COO of Benenson Capital, says the transaction brings the office building to 100% occupancy.

When it takes over its new space in April 2008, Purdue Pharma will occupy three full floors and a portion of the first floor of the 1600 Summer St. building. Tom Pajolek, SVP of CBRE's Westchester/Fairfield operations, represented Purdue Pharma. Trip Hoffman, Jodie Dostal and Fred Smith of Cushman & Wakefield acted on behalf of the ownership.

Commenting on its planned relocation move, Ed Mahony, EVP and CFO of Purdue Pharma says, "We investigated a number of options for office space and after weighing them all, we selected 1600 Summer St. We are confident this space will allow us to provide a pleasant and productive work environment for our employees."

In March 2006, Benenson Capital Partners reported it was launching a multimillion-dollar capital improvement program at the 1600 Summer St. property. The program was necessary because the property's sole tenant for the previous 15 years--General Electric Consumer Finance--moved out of the building later that year. The redevelopment was the first major capital improvement initiative at the property that Benenson Capital built in 1980.